Sherman G. Souther
@Vr Adviser, Llc
Latest period2024 - Q3ReportedManaged Assets$1.909BTotal holdings38
Assets growth rate21.59%Assets growth rate (2-Q avg)-1.85%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Vr Adviser, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 38 positions.
Assets under management
The assets under management (AUM) of Vr Adviser, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.909B in assets, with a quarterly growth rate of 21.59% and a 2-quarter average growth rate of -1.85%. The portfolio is managed by Sherman G. Souther, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
COGTCogent Biosciences Inc
| 3.22% | $61.389M 5.684M shares@ $10.81 avg price | |
DNTHDianthus Therapeutics Inc
| 2.51% | $47.761M 1.744M shares@ $27.39 avg price | Decreased -16.71% |
FDMT4d Molecular Therapeutics In
| 2.5% | $47.564M 4.4M shares@ $10.81 avg price | |
MRUSMerus N V
| 2.38% | $45.362M 907,963 shares@ $49.96 avg price | Decreased -28.12% |
ORICOric Pharmaceuticals Inc
| 2.36% | $45.044M 4.395M shares@ $10.26 avg price | |
ERASErasca Inc
| 2.32% | $44.27M 16.216M shares@ $2.74 avg price | |
PRAXPraxis Precision Medicines I
| 2.13% | $40.631M 706,131 shares@ $57.55 avg price | |
ATXSAstria Therapeutics Inc
| 2% | $38.08M 3.459M shares@ $11.01 avg price | Decreased -4.15% |
TERNTerns Pharmaceuticals Inc
| 1.49% | $28.44M 3.41M shares@ $8.35 avg price | |
AQSTAquestive Therapeutics Inc
| 1.45% | $27.667M 5.556M shares@ $4.99 avg price |